N/A N=91

Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection

SARS-CoV-2 Acute Respiratory Disease · Covid19

Bottom Line

View on ClinicalTrials.gov: NCT04371471 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2022

Primary outcome: Primary: Number of Participants With Normal and Above Triage (STC-19) Score — 52; 12; 4; 5 Participants

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: STC-19 score (Diagnostic_test)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Groupe Hospitalier de la Rochelle Ré Aunis
Primary completion: Apr 2020

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants With Normal and Above Triage (STC-19) Score	52; 12; 4; 5; 0; 8	—
SECONDARY Number of Participants With Normal and Above Genito-thyroid Index (GTi) Value	33; 4; 11; 10; 12; 11	—

Summary

During this pandemic period, the goal of the health care system is to optimize the use of intensive care services for patients infected with SARS-CoV-2, given the frequency of complications that can lead to high mortality. When patients with suspected or confirmed COVID-19 are admitted to hospital, whether or not they are symptomatic, there is currently no method to predict who will progress to complications requiring the use of intensive measures in 24-48 hours.

Eligibility Criteria

Inclusion Criteria

Patient with clinical signs of CoV-2-SARS infection
Complete blood count test and systolic blood pressure available at the time of diagnosis
Informed of the study.

Exclusion Criteria

Women beyond the 1st trimester of pregnancy
Persons under-the-age-of or legally-denied medical decision-making capacity by a judicial or administrative decision,
Persons of full age who are subject to a legal protection measure,
Persons unable to consent,
Persons who are not members of or beneficiaries of a social welfare program administered by the Republic of France
Patient's refusal to participate in the study.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04371471). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.